WallStreetZenWallStreetZen

NASDAQ: VERV
Verve Therapeutics Inc Stock Ownership - Who owns Verve Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Verve Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Joan NickersonChief Administrative Officer2024-04-021,514$8.24
$12.48kSell
Krishna YeshwantDirector2023-12-011,800,000$10.00
$18.00MBuy
Allison DorvalChief Financial Officer2023-11-29554$11.45
$6.34kSell

1 of 1

VERV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VERV insiders and whales buy or sell their stock.

VERV Shareholders

What type of owners hold Verve Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Alphabet Inc14.77%12,349,086$76.07MInstitution
Krishna Yeshwant14.55%12,168,489$74.96MInsider
Gv 2017 GP LLC12.40%10,368,489$63.87MInsider
Ark Investment Management LLC8.40%7,025,116$43.27MInstitution
Vanguard Group Inc6.54%5,471,930$33.71MInstitution
Gv 2019 GP LLC5.35%4,472,509$27.55MInsider
Blackrock Inc5.30%4,435,481$27.32MInstitution
Federated Hermes Inc4.76%3,980,372$24.52MInstitution
State Street Corp4.62%3,866,764$23.82MInstitution
Fmr LLC4.12%3,444,570$21.22MInstitution

1 of 3

VERV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VERV62.25%37.75%Net BuyingNet Selling
ALT34.70%65.30%Net SellingNet Selling
ABSI29.91%39.04%Net BuyingNet Buying
CVAC9.83%0.00%
ANL0.06%0.00%
View Top Biotech Stocks

Verve Therapeutics Stock Ownership FAQ

Who owns Verve Therapeutics?

Verve Therapeutics (NASDAQ: VERV) is owned by 89.26% institutional shareholders, 54.13% Verve Therapeutics insiders, and 0.00% retail investors. Krishna Yeshwant is the largest individual Verve Therapeutics shareholder, owning 12.17M shares representing 14.55% of the company. Krishna Yeshwant's Verve Therapeutics shares are currently valued at $74.96M.

If you're new to stock investing, here's how to buy Verve Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.